LV305, a dendritic cell-targeting integration-deficient...

Molecular Therapy — Oncolytics 2016 / 3 Vol. 3

LV305, a dendritic cell-targeting integration-deficient ZVexTM-based lentiviral vector encoding NY-ESO-1, induces potent anti-tumor immune response

Albershardt, Tina Chang, Campbell, David James, Parsons, Andrea Jean, Slough, Megan Merrill, ter Meulen, Jan, Berglund, Peter
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
3
Language:
english
Journal:
Molecular Therapy — Oncolytics
DOI:
10.1038/mto.2016.10
Date:
March, 2016
File:
PDF, 980 KB
english, 2016
Conversion to is in progress
Conversion to is failed